Instructions for Authors updated September 2020
The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication published quarterly to serve as a means for scientific information exchange in the international pharmaceutical forum. It accepts submission of original research not published or under consideration for publication anywhere else. Specific topics of interest to the journal include, but not limited to: pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, radiopharmacy, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, pharmacoepidemiology, pharmaceutical policy, pharma management, biotechnology, nanotechnology, biopharmaceutics and physical pharmacy. The paper must report novel findings based on an extensive and thorough study. Papers with didactic orientation, bulletins and subjects of exclusively local interest will not be considered for publication.
The manuscript should provide full and appropriate credit to all who contributed to the experimental data and their interpretation and discussion. Each manuscript must be accompanied by a cover letter signed by the corresponding author on behalf of all the authors that its publication has been approved by all coauthors, if any, as well as by the responsible authorities at the institute where the work has been carried out. The cover letter should explicitly state that the manuscript has not been previously published in any language anywhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and that it is not under simultaneous consideration by another journal. Moreover, Iranian Journal of Pharmaceutical Research will not publish any manuscript unless the chemical structures of all compounds are fully disclosed, either by reference to prior work providing such data or by enclosure of such data in the manuscript.
A statement transferring copyright from the authors (or their employers, if they hold the copyright) to School of Pharmacy, Shahid Beheshti University of Medical Sciences will be required before the manuscript can be accepted for publication.
All the articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g. as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic databases, video disks, etc. without first obtaining written permission from the publisher. The use of general descriptive names, trade names, trademarks, in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
Ethics in Animal and Clinical Investigations
Investigation using experimental animals must contain a statement confirming the adherence of the research to the ethics guidelines of the institute. Investigation involving human subjects should be in accordance with the Helsinki Declaration of 1975 (revised in 2008) and be approved by the institutional ethics committee or equivalent; and this should be stated in the “Methods” section.
In case of any doubt about the adherence of the research to the Helsinki Declaration, it should be demonstrated that the doubtful aspects have been explicitly approved by the relevant institutional ethics committee, and the rational for the approach should be explained.
In clinical studies involving human subjects, the patient’s right to privacy should be considered and any form of identifying information should not be published unless this is necessary for scientific purposes and the patient gives written informed consent. In this case, this should be indicated in the manuscript. Manuscripts reporting clinical trial data should provide the registration number of the study in the text of the manuscript.
All submissions fulfilling the journal’s requirements (regarding the field, format, the English language, and scientific quality and significance) will be reviewed anonymously by three or more national and international referees expert in the field, at least two of which are out of the editorial board members (preferably one from the scientifically advanced countries). The corresponding author could also suggest potential reviewers to the journal at the time of submission. However, the editorial board reserves the right to select or refuse to use the suggested potential reviewers. For more information regarding the manuscript review process, the authors could refer to the specific link "Journal Info: Peer Review Process".
Original research works in two forms of research paper or short communication could be submitted for consideration for publication. The review articles and commentaries are only accepted by invitation. The manuscripts should be written in clear and concise English. They should be prepared in accordance with the “Uniform Requirements for Manuscripts Submission to Biomedical Journals” proclaimed by the International Committee of Medical Journal Editors. Authors are responsible for all statements made in their work. The right is reserved to incorporate any changes deemed necessary by the Editorial Board to make contributions harmonize the editorial standards of the Journal.
The prepared manuscript should be submitted online to the following address: www.ijpr.ir. The manuscript should be in word 2003 (or later) format. The entire article should be submitted as a single file. Do not insert tabs in references. Use one hard return at the end of each reference.
For information about the structure of the articles, the authors should read the instructions below. It is also suggested to refer to the latest issue of the journal (available online).
Structure of Articles
Research papers, short communications, as well as review articles and commentaries (the two latter are only accepted by invitation) that address the scope of the journal will be considered for publication. The Articles should include title page, abstract, keywords, introduction, Literature review (optional), experimental (Materials and Methods), results and discussion, Conclusion (optional), acknowledgements, conflict of interest, author contributions, references, tables, figures, and legends, enumerated from the title page. While there are no fixed limitations to the length of an article, authors are asked to write their manuscripts in a clear and concise manner and to include only data crucial to arriving at their final conclusions. Research papers should include up to 10 figures/tables. Short Communications are preliminary or final reports limited to approximately 1500 words. They must be of sufficient importance and general interest to justify accelerated publication. Commentaries represent the author’s considered opinion within the scope of the journal. If the commentary criticizes an article published in the journal, the authors of the original article will be given an opportunity to reply in the same issue in which the commentary is published. Reviews are accepted by invitation only. Authors interested in preparing a commentary or review Article should provide a brief outline to the editor, requesting an invitation to submit a manuscript in one of those categories. Review manuscripts must be an in impactful developments, the challenges and future trends in the field. Review manuscripts should be of the highest quality on initial submission submitted by a well-known author who has at least 10 published papers in the field and should not need considerable language improvements.
For formatting: Use a normal, plain font (preferably Times new Roman, 12 point) for text. Double space the text. Use the automatic page numbering function to number the pages. Use the left-to-right direction and alignment for body text. Authors should consult a recent issue of the journal for style if possible. The Editors reserve the right to adjust style to certain standards of uniformity. The authors should check the spelling, grammar, and punctuations in their submissions. An acceptable manuscript should deeply represent a recent "high quality" work in an important topic.
A manuscript submitted in poor English will be returned without review. Permission should be obtained for use of copyrighted materials from other sources.
Title Page: Title of the manuscript should truly reflect purpose and findings of the study. The title should not be too long and the authors should avoid using abbreviations in the title of manuscript. Title page should contain title, author names (first name family name), affiliations, running title(≤50 characters, including spaces), name and address of author to whom correspondence and reprint requests should be addressed. Notice that maximum two authors can contribute equally as first authors .
Highlights: Highlights increase the visibility of your manuscript via search engines. They can be about the new methods used in the study or the novelty of your work. Highlights should consist of a short collection of 3-5 bullet points (maximum 85 characters, including spaces).
Abstract: This should not be structured but should include the title, aims, methods, results, and conclusion. It should not be more than 250 words.
Keywords: For indexing purposes, each submitted article should include five to seven keywords, preferably chosen from the Medical Subject Headings (MESH).
Graphical abstract: Agraphical abstract is mandatory for this journal. It should clearly present the objectives of the study in a concise picture to capture the reader’s attention. Graphical abstract should be submitted as a separate file in the online submission system. Please provide a picture at a size of 531×1328 pixels (h × w) with minimum resolution of 300 dpi. Preferred file types: PNG, JPG, JPEG. File should not be larger than 1 MB.
Introduction: Introduction of a manuscript should be brief (save rest for discussion) with an adequate background, avoiding a detailed literature review or a summary of the results . Introduce any unusual terms used for the study. Make sure all data/claims referenced. An acceptable introduction should address the following questions;
Experimental: The Experimental should contain “protocols” of the study with enough details to allow the work to be reproduced by an independent researcher. Also provide an outline of statistical methods used, if appropriate. Give definitions (e.g. outcomes measures).
Results: Results section should follow directly from the Materials and Methods section (the Materials and Methods section should tell what types of Results are to be looked for); no “new” or “unanticipated” results should be presented that don’t follow from the Materials & Methods. The presentation order of results should parallel the presentation order of methods.
Discussion: The discussion should state whether hypothesis was verified or proven untrue, or (if no hypothesis) what questions were answered or why the report is important. Should comment as to whether the results are in line with prior studies. If not, an attempt should be made to explain the discrepancies. Review only those parts of the medical literature relevant to the study. Note (preferably in a separate paragraph) limitations of the study.
Conclusions: State the main conclusion of the study in one paragraph.
Acknowledgments: In this section any financial support, scientific or technical assistance, gifts, etc... should be acknowledged. Permission from the parties being acknowledged should be obtained.
Conflict of interests: Any information regarding the potential conflict of interests related to various aspects such as financial support by commercial firms, etc… should be disclosed in manuscripts to help clarify this issue.
Author contributions: The authors’ individual contributions (the authorship) should be stated based on the relevant credit roles: Substantial contributions to the conception or design of the work, data analysis or interpretation, funding source, drafting the work or revising. If all authors contributed equally, please state in the manuscript.
References: The authors are responsible for the accuracy of the bibliographic information. References must be numbered consecutively in order of citation in the text. Mark reference citations in parentheses. Personal communications, unpublished data, including manuscripts submitted but not already-accepted for publication, may also be used as a reference.
Periodical titles should be abbreviated according to the Index Medicus. Inclusive page numbers should be given for all references. Print surnames and initials of all authors. Do not use “et al”. References to web sites, web pages or other electronic sources should include access date of the data. The style and punctuation of the references should conform to the following examples:
(1) Standard journal article:
Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J and Lusis AJ. Paraoxonase and coronary heart disease. Curr. Opin. Lipidol. (1998) 9: 319-24.
(2) Article, no author given:
Cancer in South Africa [editorial]. S. Afr. Med. J. (1994) 84: 15-16.
(3) Chapter in a book:
Phillips SJ and Whisnant JP. Hypertension and stroke. In: Laragh JH and Brenner BM. (eds.) Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. Raven Press, New York (1995) 465-78.
(4) Book, personal author(s):
Ringsven MK and Bond D. Gerontology and Leadership Skills for Nurses. 2nd ed. Delmar Publishers, New York (1996) 123-5.
(5) Book, editor(s) as author:
Norman IJ and Redfern SJ. (eds.) Mental Health Care for Elderly People. Churchill Livingstone, New York (1996) 89-92.
(6) Book, Organization as author and publisher:
Institute of Medicine (US). Looking at the Future of the Medicaid Program. The Institute, Washington (1992) 23-6.
(7) Article in electronic form:
Morse SS. Factors in the Emergence of Infectious Diseases. Emerg. Infect. Dis. [serial online] 1995 Jan-Mar [cited 1996 Jun 5], 1: [24 screens]. Available from: URL: http://www.cdc.gov/ncidod/EID/eid.htm.
(8) Conference proceedings:
Kimura J and Shibasaki H. (eds.) Recent Advances in Clinical Neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology, 1995 Oct 15-19, Kyoto, Japan. Elsevier, Amsterdam (1996).
(9) Conference paper:
Bengtsson S and Solheim BG. Enforcement of data Protection, Privacy and Security in Medical Informatics. In: Lun KC, Degoulet P, Piemme TE and Rienhoff O. (eds.) MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland.
Kaplan SJ. Posthospital Home Health Care: The Elderly’s Access and Utilization [dissertation]. St. Louis, Washington University (1995) 78-80.
Tables: The Tables should provide easier understanding and not duplicate information already included in the text or figures. Tables should be submitted as editable text and not as image. Table direction should be left-to-right as the small plus at the top corner shows. Please submit tables as a separate word file (one table in each page) in the online submission. Number tables consecutively as cited in the text.Tables should contain all borders. Please ensure that tables are inserted next to the relevant text in the manuscript as well.
Figures: Photographs, charts, and diagrams are all to be referred to as ²Figure(s)². All Figures should be in one of the formats (JPG, JPEG, PNG) to a minimum of 300 dpi. Figures should be numbered consecutively as cited in the text. The name and footnote of the figure should not be included in it. They should be included only if they augment understandability of the text. Drawings and graphs should be professionally prepared in deep-black and submitted as glossy, black-and-white clean Photostats. Professionally designed computer generated graphs with a minimum of 300 dpi laser printer output is also acceptable. Each figure should have a label on the back, listing the figure number, title of manuscript, first author, and an arrow indicating the top. Color photographs are welcome at no extra charge. Please ensure that figures are inserted next to the relevant text in the manuscript.
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum. Maximum two authors can be designated as the corresponding authors with contact details (email address, full postal address).
Since April 2018, IJPR requires an ORCID ID for all corresponding authors at the time of manuscript submission. Please click here to register for an ORCID ID.
Manuscripts must be devoid of any forms of plagiarism. They should also have appropriate citations to the related literature in the field.
Individuals interested in any document can contact the corresponding author or our web site; all IJPR documents are freely available online at http://www.ijpr.ir.
Authors who have affiliation with Iranian institutes
For manuscripts submitted 1 Feb 2021 and later, IJPR will charge authors for publication of their accepted articles at a fee of IRR 20,000,000 per article. Publication charge waivers or discounts are granted on a case-by-case basis. Authors can request a waiver or discount after acceptance of the manuscript. For more information please contact the Editorial Office by e-mail at email@example.com.
For further information, please contact the Editorial Office through:
©Copyright 2021 Iranian Journal of Pharmaceutical Research